ORAI3 and plasma cell myeloma: An interesting finding has been reported in tipifarnib-sensitive leukemia and multiple myeloma cell lines where Orai3 is responsible for tipifarnib-mediated Ca2+ overload, which, in turn, plays an essential role in the cytotoxic effects of tipifarnib (Figure 2).